Efficacy of Oral Nanoparticle-Encapsulated Insulin in Reducing Oxidative Stress and Enhancing Tissue Integrity in a Diabetic Rat Model
Nawel Kaddour,Farah Benyettou,Kawtar Moulai,Abdelouahab Mebarki,Rose Ghemrawi,Zine-Charaf Amir,Hafida Merzouk,Ali Trabolsi,Nassima Amel Mokhtari-Soulimane
DOI: https://doi.org/10.2147/ijn.s468756
IF: 7.033
2024-10-29
International Journal of Nanomedicine
Abstract:Nawel Kaddour, 1 Farah Benyettou, 2 Kawtar Moulai, 1 Abdelouahab Mebarki, 1 Rose Ghemrawi, 3, 4 Zine-Charaf Amir, 5 Hafida Merzouk, 1 Ali Trabolsi, 2 Nassima Amel Mokhtari-Soulimane 1 1 Laboratory of Physiology, Physiopathology, and Biochemistry of Nutrition, Department of Biology, Faculty of Sciences of Nature and Life, Earth Sciences and Universe (SNVSTU), University of Tlemcen, Tlemcen, 13000, Algeria; 2 Chemistry Program, New York University Abu Dhabi (NYUAD), Abu Dhabi, 129188, United Arab Emirates; 3 College of Pharmacy, Al Ain University, Abu Dhabi, P.O. Box 112612, United Arab Emirates; 4 AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, P.O. Box 112612, United Arab Emirates; 5 Department of Anatomy and Pathological Cytology, University Hospital Center Mustapha Pacha, Algiers, Algeria Correspondence: Nassima Amel Mokhtari-Soulimane, Faculty SNVSTU University of Tlemcen, BP 119, Rocade 2 Mansourah, Tlemcen, 13000, Algeria, Tel +213 557 229 623, Email ; Ali Trabolsi, Chemistry Program, New York University Abu Dhabi (NYUAD), Abu Dhabi, 129188, United Arab Emirates, Tel +971 26284575, Email Introduction: Diabetes mellitus, a chronic metabolic disorder, leads to systemic organ damage characterized by oxidative stress and structural alterations, contributing to increased morbidity and mortality. Traditional subcutaneous insulin therapy, while managing hyperglycemia, often falls short in addressing the oxidative damage and preventing organ-specific complications. This study evaluates the therapeutic efficacy of a novel oral nanoparticle-mediated insulin (nCOF/Insulin) against these diabetes-induced changes, comparing it with traditional subcutaneous insulin in a streptozotocin (STZ)-induced diabetic rat model. Methods: We induced diabetes in Wistar rats, dividing them into four groups: standard control, diabetic control, diabetic treated with subcutaneous insulin, and diabetic treated with oral nanoparticle-mediated insulin (nCOF/Insulin). Assessments included organ and body weights, histopathological examinations, and oxidative stress markers (MDA and PCOs) across various organs, including the brain, muscle, intestine, spleen, heart, liver, kidney, and adrenal glands. Additionally, we evaluated antioxidant parameters (GSH and catalase) and conducted immunohistochemical analysis of E-cadherin to assess intestinal integrity. Results: Our findings reveal that STZ-induced diabetes significantly impacts organ health, with subcutaneous insulin providing limited mitigation and, in some cases, exacerbating oxidative stress. Conversely, oral nCOF/Insulin treatment effectively restored organ and body weights, reduced oxidative stress markers, and mitigated histological damage. This suggests that oral nCOF/Insulin not only offers superior glycemic control but also addresses the underlying oxidative stress. Conclusion: nCOF/Insulin emerges as a promising treatment for diabetes, with the potential to improve patient quality of life by ameliorating oxidative stress and preventing organ-specific complications. This study underscores the need for further investigation into the long-term effects and mechanisms of action of oral nCOF/Insulin, aiming to revolutionize diabetes management and treatment strategies. Keywords: oral nanoparticle-mediated insulin, diabetes mellitus, oxidative stress, organ toxicity, diabetic complications Diabetes mellitus is a group of metabolic disorders marked by persistent hyperglycemia. 1 Over half a billion people are living with diabetes worldwide, which represents more than 10.5% of the world's adult population. 2 This widespread prevalence underscores its status as a major global health challenge. 1 Diabetes mellitus, a complex metabolic disorder, is intricately linked to systemic oxidative stress, a key factor in its pathogenesis. It is now understood that the onset of diabetes originates from oxidative stress within pancreatic cells, which triggers inflammation and prompts the release of pro-inflammatory cytokines, ultimately leading to the death of pancreatic beta cells. 3,4 This loss of beta cells results in hypoinsulinemia and hyperglycemia, which in turn creates a vicious cycle of oxidative stress throughout the organism. 5,6 This systemic oxidative stress then triggers functional and structural alterations in various organs, leading to diabetes-related complications and consequently making diabetes one of the principal causes of mortality and morbidity worldwide. 7–9 The contemporary understanding of diabetes has evolved to recognize it as a complex dysglycemic diso -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology